IP Verse

Methods For Treating Pain By Administering An Antagonist Antibody Against The Nerve Growth Factor And An Opioid Analgesic, And Compositions Containing The Same - EP2100902B1

PatentPatent Analysis

EP2100902

RINAT NEUROSCIENCE
Application Number
EP09163527A
Filing Date
Oct 8, 2003
Status
Revoked
Oct 11, 2024
Grant Date
Dec 18, 2019
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2206728B9
EP2305711B1

Bibliography

The patent EP2100902B1 was granted to Rinat Neuroscience on Dec 18, 2019 following the initial filing on Oct 8, 2003 under the application number EP09163527A . The current legal status of the patent is Revoked.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

REGENERON PHARMACEUTICALSSep 18, 2020ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents